Grail Launches Galleri Multi-Cancer Test In US; Future Of Merger With Illumina Is Still Uncertain

The company launched the lab test in the US. New results from PATHFINDER trial showed an earlier version of Galleri can detect many types of cancer, including early-stage cancer that has yet to metastasize.